Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemotherapy in Locally Advanced NSCLC.
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
Our aim is to conducted a multicenter phase II trial of the cisplatin-oral vinorelbine
-radiotherapy combination after induction chemotherapy with cisplatin-docetaxel in patient
with NSCLC. Oral vinorelbine will be used in the present study rather than the intravenous
form because: 1- Previous investigations have demonstrated that oral vinorelbine is as
effective as the intravenous form in the treatment of NSCLC. 2 - We think that the use of
oral agents in CT will reduce some disagreements provoked by intravenous injections: stress,
infections, hemorrhage, displacement at the hospital and cost of CT.
.